NMA Takes Stand Against Painful Diabetic Peripheral Neuropathy (DPN)
The National Medical Association (NMA), the nation’s oldest and largest medical association representing the interest of over 50,000 African American physicians and the patients they serve, and pharmaceutical company Pfizer are working together to raise awareness of painful diabetic peripheral neuropathy (DPN).
LIKE BlackDoctor.org on Facebook! Get Your Daily Medicine…For LIFE!
[ione_facebook_like_box url_segment=blackdoctor.org height=”260″]
Peripheral neuropathy is nerve damage caused by chronically high blood sugar and is the most common complication of diabetes. With painful symptoms including burning and shooting pains in the hands and feet, and the feeling of sharp pins and needles, diabetic nerve pain is a growing problem in the black American community where an estimated 1 in 5 black Americans has diabetes. Black Americans are also nearly three times as likely as non-Hispanic whites to have a lower-extremity amputation due to diabetes complications.
Treating DPN is an important part of a patient’s overall diabetes management plan. To help address painful DPN with their clients, the NMA and Pfizer are making two new DPN diagnosis and treatment resources available to NMA members.